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Abstract
Background: The chondroitin sulphate proteoglycan NG2 blocks neurite outgrowth in vitro and
has been proposed as a major inhibitor of axonal regeneration in the CNS. Although a substantial
body of evidence underpins this hypothesis, it is challenged by recent findings including strong
expression of NG2 in regenerating peripheral nerve.
Results: We studied axonal regeneration in the PNS and CNS of genetically engineered mice that
do not express NG2, and in sex and age matched wild-type controls. In the CNS, we used
anterograde tracing with BDA to study corticospinal tract (CST) axons after spinal cord injury and
transganglionic labelling with CT-HRP to trace ascending sensory dorsal column (DC) axons after
DC lesions and a conditioning lesion of the sciatic nerve. Injury to these fibre tracts resulted in no
difference between knockout and wild-type mice in the ability of CST axons or DC axons to enter
or cross the lesion site. Similarly, after dorsal root injury (with conditioning lesion), most
regenerating dorsal root axons failed to grow across the dorsal root entry zone in both transgenic
and wild-type mice.
Following sciatic nerve injuries, functional recovery was assessed by analysis of the toe-spreading
reflex and cutaneous sensitivity to Von Frey hairs. Anatomical correlates of regeneration were
assessed by: retrograde labelling of regenerating dorsal root ganglion (DRG) cells with DiAsp;
immunostaining with PGP 9.5 to visualise sensory reinnervation of plantar hindpaws; electron
microscopic analysis of regenerating axons in tibial and digital nerves; and by silver-cholinesterase
histochemical study of motor end plate reinnervation. We also examined functional and anatomical
correlates of regeneration after injury of the facial nerve by assessing the time taken for whisker
movements and corneal reflexes to recover and by retrograde labelling of regenerated axons with
Fluorogold and DiAsp. None of the anatomical or functional analyses revealed significant
differences between wild-type and knockout mice.
Conclusion: These findings show that NG2 is unlikely to be a major inhibitor of axonal
regeneration after injury to the CNS, and, further, that NG2 is unlikely to be necessary for
regeneration or functional recovery following peripheral nerve injury.
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NG2 is a large transmembrane proteoglycan of the chon-
droitin sulphate proteoglycan (CSPG) family, with a large
ectodomain and a short cytoplasmic tail [1,2]. It is
expressed in many different tissues, especially during
development, but in the adult mammalian brain and spi-
nal cord, it is expressed predominantly by a subset of glial
cells with astrocyte-like morphology and the antigenic
characteristics of oligodendrocyte progenitor cells [3].
These cells are present throughout white and grey matter
at a density similar to that of oligodendrocytes and micro-
glial cells, and in recent years it has been proposed that
they constitute a novel class of glial cells (for which the
term polydendrocytes has been proposed) with as yet
poorly understood roles in adult nervous system function
[3-5].
There is evidence from studies in vitro that NG2, like most
other CSPGs, inhibits neurite outgrowth in culture [6],
and possesses several domains that cause growth cone col-
lapse [7]. It has also been shown that antibodies against
NG2 block its inhibitory effects on neurite growth [8] and
that among a variety of CSPGs expressed by a growth-
inhibitory astrocyte cell line, NG2 is the one with by far
the strongest inhibitory effects on neurite growth [9]. This
evidence is complemented by evidence, from in vivo stud-
ies, that NG2 is present at sites at which regenerative
growth of axons within or into the CNS is arrested, nota-
bly around CNS injury sites and at the dorsal root entry
zone (DREZ), where NG2-expressing cells proliferate and
accumulate after injury [10-15]; see reviews by Butt et al,
2002 [4], and Nishiyama, 2007 [16].
Findings such as these have led to a widespread belief that
NG2 is one of the major inhibitors of axonal regeneration
within or into the mammalian CNS after injury [17], a
view that has been strongly reinforced by recent work
reporting that neutralising monoclonal antibodies against
NG2 applied at dorsal column lesion sites in adult rats,
promote regeneration of sensory axons into the lesion
site, and when combined with a conditioning lesion of
the sciatic nerve, result in regenerative growth of axons
rostral to the lesion site [18].
However, in addition to abundant evidence for the pres-
ence in the CNS of other molecules which are thought to
inhibit regenerative axonal growth (including Nogo, mye-
lin associated glycoprotein and oligodendrocyte myelin
glycoproteins), there are numerous findings that cast
doubt on the general validity of the view that NG2 is a
major axon growth inhibitor and suggest the need for fur-
ther investigation. For example, AN2, the mouse homo-
logue of NG2, does not inhibit outgrowth of mouse
dorsal root ganglion (DRG) cell neurites growing on a
laminin substrate [19] and mouse cerebellar granule cells
adhere to and extend neurites on substrates containing
AN2 [20]. Also, whereas NG2 inhibits neurite outgrowth
from rat cerebellar granule cells plated on a substrate of L1
(an axon-growth-promoting cell adhesion molecule), it
has no effect on the outgrowth of neurites from DRG cells
on the same substrate [6] suggesting that the inhibitory
effects of NG2 are exerted selectively on only some types
of neuron. There is also evidence that regenerating CNS
axons may grow through regions rich in NG2-expressing
cells [14,21]. Moreover, in very recent work, it has been
shown that NG2-expressing cells promote neurite out-
growth from hippocampal and neocortical neurons in
vitro and that both in vitro and in vivo NG2-expressing
cells are preferentially and extensively contacted by axonal
growth cones [22], in keeping with earlier evidence that
NG2-expressing cells may receive synaptic input from
glutamatergic axons [23,24].
The presence of NG2 in the normal and regenerating PNS
raises further questions about its roles. NG2 is expressed
by fibroblast-like cells and microvascular pericytes in
peripheral [11,15,25], is present at nodes of Ranvier
[15,26] and may also be expressed by a subset of non-
myelinating Schwann cells [19]. Moreover, the peripheral
axons of DRG cells in the sciatic nerve regenerate through
the prominent cap of NG2-positive cells that forms over
the proximal stump following resection of the nerve, and
continue to grow along the distal stump in close proxim-
ity to NG2-expressing cells [15]. Such observations sug-
gest that NG2 has no generalised inhibitory effect on
regenerating PNS axons or that it is involved in subtle
focal inhibitory functions directed at preventing profuse
branching of the axons and/or perhaps serving to confine
regenerating axons to the bands of von Büngner.
Our approach to elucidating the possible roles of NG2 in
inhibiting axonal regeneration after injury was to com-
pare regeneration and reinnervation in a variety of well-
established CNS and PNS injury models, between normal
and NG2 knockout mice. Thus we have studied axonal
regeneration in the CNS after lesions of the corticospinal
tract and dorsal column, and at the dorsal root-spinal cord
interface following dorsal root injury. We have also exam-
ined regeneration and reinnervation in peripheral nerv-
ous system following facial and sciatic nerve injuries.
Results
Analysis of phenotype
For all of the studies reported below, identification of
knockout and wild-type mice was based on immunohis-
tochemical phenotyping of tail snips with anti-NG2 anti-
body, which provided unequivocal evidence for the
absence or presence of NG2 (see Fig. 1). No differences
were apparent between knockout and wild-type mice withPage 2 of 22
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of brain and spinal cord.
CNS injury models
Dorsal column injury
Following dorsal column lesions (and all other types of
experimental injury) no differences were apparent at
autopsy or in overall histological appearance of the lesion
site or other areas of CNS tissue, between knockout and
wild-type mice. In all cases the dorsal column above and
below the lesion site was separated by a zone of collagen-
ous connective tissue (scar tissue) which was adherent to
the overlying meningeal tissue and was often lost during
tissue processing, leaving a cyst-like cavity.
In both knockout and wild-type mice surviving 28 days
after transection of the dorsal column at T8 (and sciatic
conditioning lesion), axons labelled transganglionically
with CT-HRP were present in the dorsal column below the
level of the lesion (Figs. 2a, b), but with the exception of
a small number of axons which appeared to penetrate into
the most caudal region of the lesion (Figs. 2c, d), labelled
axons were not detected at more rostral levels (Figs. 2e, f).
Furthermore, most of the labelled axons at the caudal
margin of the lesion displayed enlarged end-bulbs sug-
gesting arrested regeneration at this level. Systematic
examination of serial sections showed no labelled axons
growing around the lesion or bypassing it ventrally.
Dorsal root injury
In both knockout and wild-type mice 28 days after L5 dor-
sal root transection (and sciatic nerve conditioning
lesion) labelled axons (transganglionic CT-HRP) were
present in the dorsal root central to the injury site. How-
ever, the great majority appeared to be arrested at the
DREZ where some formed end-bulbs (Figs. 3a, b) and
some appeared to turn back into the root (Fig. 3a). No
labelled axons were detected in the dorsal column or dor-
sal column nuclei (Fig. 3c) in either knockout or wild-type
animals.
Corticospinal tract injury
Twenty-one days after transection of the dorsal column
(incorporating the corticospinal tract, CST) at C6 and
anterograde labelling of CST axons with BDA injected into
the contralateral sensorimotor cortex, labelled axons were
abundant in the CST rostral to the injury site but appeared
to be arrested at the rostral border of the latter in both
wild-type (Figs. 4a, b) and knockout mice (Figs. 4c, d).
Many of the labelled axons displayed terminal end-bulbs
in this area. No labelled axons penetrated the lesion site,
none was observed bypassing the lesion site laterally or
ventrally, none was found in the dorsal part of CST caudal
to the lesion site, and there was no evidence to suggest
that axons in the injured CST had grown or sent branches
into the intact contralateral CST in either group. Fine lat-
eral branches were observed to emerge from labelled CST
axons rostral to the lesion site (not illustrated) but these
were as likely to have been normal collateral branches as
regenerative sprouts and no difference in the distribution
Phenotyping of tailsnipsFigure 1
Phenotyping of tailsnips. Longitudinal sections of tail snips from a wild-type mouse (a) and a knockout mouse (b) immuno-
reacted with anti-NG2 antibody. Arrowheads delineate the edges of the tail snip sections. Strong NG2 immunofluorescence is 
apparent in hair follicles (h), sebaceous glands (s) and bone marrow (bm) and other structures in Fig. 1a but no NG2 fluores-
cence is detectable in Fig. 1b. Bar = 200 µm and also applies to Fig. 1b.Page 3 of 22
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Transganglionic labelling with CT-HRP of dorsal column axons after spinal cord injuryFigure 2
Transganglionic labelling with CT-HRP of dorsal column axons after spinal cord injury. Horizontal sections 
through the dorsal columns of the spinal cord of wild-type (Figs. 2a, c, e) and knockout (Figs. 2b, d, f) mice 28 days after unilat-
eral transection of the dorsal column and ipsilateral sciatic nerve crush, and 3 days after injection of CT-HRP proximal to the 
sciatic nerve crush site. All sections were reacted for HRP. In Figs. 2a and b, at the lesion site (lesion marked with an asterisk 
and adjacent area enlarged in Figs. 2c and d) there is no indication of more extensive labelling or increased sprouting into or 
around the lesion site in the knockout relative to the wild-type control, and in both many axons displayed enlarged end bulbs 
(e.g. at arrows). Figs. 2e and f are taken approximately 2mm rostral to the lesion site. There are no regenerating or spared 
axons in the injured dorsal column in either. The dotted lines mark the midline; the injured dorsal column is below (to the left 
of) the midline in both figures. The orientation markers in Figs. 2a and b show medial (m) and caudal (c) for the left (injured) 
dorsal column. Scale bars = 100 µm; the bar in Fig. 2a applies to 2b also; the bar in Fig. 2c applies to 2d–f also.
BMC Neuroscience 2007, 8:80 http://www.biomedcentral.com/1471-2202/8/80or frequency of such side branches was detected between
knockout and wild-type mice.
Functional recovery after peripheral nerve injury
Sciatic nerve crush and transection
Recovery of sensory function, as a measure of the rate and
extent of regeneration of sensory axons in the injured sci-
atic nerve, was assessed by twice-daily monitoring of the
withdrawal reflex in response to stimulation of the lateral
hindpaw with Von Frey hairs from 1 day following nerve
injury to 2 days after full recovery was first observed. The
threshold stimulus for eliciting withdrawal was identical
for both hindpaws preoperatively and for the control
hindpaw postoperatively in both wild-type and knockout
mice. After sciatic nerve crush, wild-type mice recovered
the preoperative withdrawal reflex threshold after a mean
of 10.2 days and knockout mice after a mean of 9.8 days
(p = 0.63 n.s.; Fig. 5a). After simultaneous excision of 3
mm of the saphenous nerve, recovery times were not sig-
nificantly different: the withdrawal reflex was restored by
10.3 days in wild-type mice and by 11.0 days in knockout
mice (p = 1.0, n.s. (calculated using a two tailed Fisher
exact test because all 6 NG2 knockout mice recovered on
the same day); Fig. 5b). These results confirm that recov-
ery times after sciatic nerve injury alone could not be due
to reinnervation as a result of sprouting from branches of
the saphenous nerve, which, if it occurred, might give rise
to false positive results. After sciatic nerve section and rea-
nastamosis, which presents a greater barrier to regenera-
tion than crush injury, recovery times were 16.7 days on
average for wild-type and 15.3 days for knockout mice (p
= 0.18 n.s.; Fig. 5c).
Recovery of motor function, as a measure of the rate and
extent of regeneration of motor axons in the injured sci-
atic nerve, was assessed at the same time that sensory func-
tion was tested, by recording the toe spreading reflex when
the hindpaw is raised above the supporting surface (this
test is dependent on motor innervation of hindpaw mus-
cles and is lost after sciatic nerve injury). The toe spreading
reflex was restored, on average, at 8.5 days in wild-type
and 9.2 days in knockout mice after sciatic nerve crush (p
= 0.36 n.s.; Fig. 5a) and at 10.7 versus 10.3 days after
simultaneous sciatic nerve crush and saphenous nerve
resection (p = 0.50 n.s.; Fig. 5b). After sciatic nerve
transection and reanastamosis, the toe-spreading reflex
recovered on average after 17.4 days in the wild-type ver-
sus 20.8 days in the knockout mice, but this apparent 3-
day lag in recovery of knockout mice was not statistically
significant (p = 0.06; Fig. 5c).
Facial nerve crush
Recovery of motor function after facial nerve crush was
assessed twice daily, from 1 to 14 days postoperatively, by
monitoring spontaneous whisker twitching and the cor-
Transganglionic labelling with CT-HRP of dorsal roots after transection and cond tioning lesionFigure 3
Transganglionic labelling with CT-HRP of dorsal 
roots after transection and conditioning lesion. The 
dorsal root entry zone (DREZ) of a wild-type (Fig. 3a) and 
knockout mouse (Fig. 3b) in horizontal sections and the dor-
sal column nucleus (DCN) in transverse section 28 days after 
transection and reapposition of the cut ends of the L5 dorsal 
root and crush of the ipsilateral sciatic nerve, and 3 days after 
injection of CT-HRP into the sciatic nerve proximal to the 
crush site. All sections were reacted for HRP. In both the 
wild-type and knockout almost all labelled axons (e.g. at 
arrows) stopped at the DREZ or turned back towards the 
dorsal root. The dorsal columns (DC) are devoid of labelled 
axons in both. The area indicated by the large arrowhead in 
Fig. 3a is enlarged in the inset, and illustrates a regenerating 
axon (indicated by small arrowheads) that turns back at the 
DREZ and displays a large terminal end bulb. Fig. 3c shows 
absence of labelled (spared) axons at the level of the DCN in 
a wild-type mouse. Scale bar = 100 µm and applies also to 3b 
and c. Inset scale bar = 50 µm.Page 5 of 22
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days to recover in the 4 wild-type animals and 9.7 days in
the 4 knockout animals (p = 0.65, n.s.; Mann-Whitney),
with the corneal reflex recovering in 9.3 days versus 9.7
days (p = 0.65, n.s.; Mann-Whitney). Thus there was no
significant difference between wild-type and knockout
mice with respect to regeneration of facial nerve axons
(Fig. 6d).
Anatomical studies after peripheral nerve injury
Retrograde labelling of DRG cells
The number of DRG cells with axons that had regenerated
into the glabrous skin of the hindpaw at various time
points following sciatic nerve crush was determined by
retrograde labelling with DiAsp to provide information
on both the extent and timing of reinnervation. Di Asp
was injected two days prior to sacrifice, because it takes
this time to be taken up by the axons and retrogradely
transported in sufficient quantity to fill the neuronal cell
bodies. Because of variable uptake of DiAsp after injection
into the hindpaw and variability in the intensity of neuro-
nal cell body labelling, the threshold for identifying (and
counting) labelled cells was set at a relatively high level.
The numbers of labelled cells recorded may therefore rep-
resent gross underestimates of the actual number of DRG
cells with regenerated axons. In all cases both feet were
Anterograde labelling with BDA of the CST after spinal cord injuryFigu e 4
Anterograde labelling with BDA of the CST after spinal cord injury. Horizontal sections of the deep dorsal columns 
of low cervical spinal cord at and immediately rostral to the site of a unilateral transection of the dorsal column (including the 
CST) 21 days after the lesion and simultaneous anterograde labelling of the CST by application of BDA to the contralateral sen-
sory-motor cortex, in a wild-type mouse (Fig. 4a, enlarged in Fig. 4b) and a knockout mouse (Fig. 4c, enlarged in Fig. 4d). There 
is no apparent enhancement of labelling in the knockout mouse relative to the wild-type, and in both examples CST axons ter-
minate just rostral to the lesion cavity (asterisk in Figs. 4a and c), some with large end bulbs (e.g. arrows in Figs. 4b and d). The 
apparent labelling medial to the injury site in Fig. 4c is actually non-specific autofluorescence. The orientation markers on Figs. 
4b and d show medial (m) and caudal (c). Scale bars on Figs. 4a and b = 100 µm and apply also to 4c and d.Page 6 of 22
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made in both ipsilateral and contralateral L4 and L5 DRG
as a control for inter-animal variability in uptake of
DiAsp.
At 5 and 9 days after sciatic nerve crush (2 animals at each
survival time), the contralateral DRG were heavily
labelled but there were no labelled cells in ipsilateral L4 or
L5 DRG (data not shown) indicating that the crush
lesions were complete, that L4 and L5 DRG are not
labelled via routes other than injured sciatic nerve, and
that regenerating sensory axons had not reached the hind-
paw at these survival times. Very few labelled neurons
were present in the ipsilateral DRG 13 days after sciatic
nerve crush (i.e. 11 days after DiAsp injection into hind-
paw), in either wild-type or knockout mice, with an aver-
age of 28 labelled neurons per DRG in wild-type mice
compared to 14 in knockout mice (p = 0.18 n.s.; Figs. 7a,
b and 7f). The appearance of retrograde label in injured
DRG neurons 13 days after sciatic nerve crush, but not
before, correlates with the onset of functional recovery
being 9–10 days after sciatic nerve crush in our other
experiments (see Figure 5a and 5b).
Much larger numbers of labelled DRG cells were present
90 days after injury, averaging 424 per DRG in the wild-
type mice and 677 in the knockout mice (p = 0.27 n.s.;
Figs. 7d, e and 7g). Thus, differences between wild-type
and knockout mice groups were not significant at either
13 or 90 days after injury.
There were no significant differences in the numbers of
retrogradely labelled DRG cells in the L4/5 DRG on the
control side between wild-type and knockout mice at
either 13 days (see Fig. 7c for example); on average 138
labelled neurons in the wild-type and 135 in the knock-
out; p = 0.96) or at 90 days (on average 489 labelled cells
in the wild-type and 627 in the knockout mice; p = 0.21).
The marked phenotype-independent difference in the
number of labelled neurons in the contralateral (control)
L4 and L5 DRG at 13 days versus 90 days was, however, a
consistent and unexpected finding. A possible explana-
tion for this may be that DiAsp is a more effective retro-
grade label for DRG cells in mature animals than in young
ones.
Reinnervation of denervated endplates in the soleus muscle
The progress and extent of muscle reinnervation 7 and 10
days after sciatic nerve crush was examined by light micro-
scopy, using silver-cholinesterase histochemistry. End-
plates in control soleus muscle from both wild-type and
knockout mice were almost all innervated by a single axon
(data not shown). At 7 days after injury no endplates had
been reinnervated in either group (Fig. 8a). At 10 days,
however, there was extensive reinnervation of endplates
Functional recovery after sciatic nerve injuryigure 5
Functional recovery after sciatic nerve injury. Histo-
grams illustrating the time taken for the recovery of motor 
function (assayed by toe spreading reflex) and sensory func-
tion (assayed by sensitivity to Von Frey hairs) after peripheral 
nerve injury in wild-type (black columns) versus knockout 
mice (grey columns). Group size was N = 6 wild-type and N 
= 6 knockout for Fig. 5a and b and N = 9 wild-type and N = 9 
knockout for Fig. 5c. Standard error of the mean is indicated 
for each column. The differences between wild-type and 
knockout mice in time taken to recover sensory and motor 
function were not significant for any of the lesion groups (sci-
atic nerve crush, Fig. 5a; sciatic nerve crush and saphenous 
nerve excision, Fig. 5b; sciatic nerve transection and reanas-
tamosis, Fig. 5c).Page 7 of 22
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and no consistent differences in the appearance of the
endplates were observed between the two groups. The
mean percentage of non-innervated endplates at 10 days
was 2.1% in wild-type and 3.1% in knockout mice (p =
0.18 n.s.) and the proportion of endplates reinnervated by
a single axon was 91.3% in wild-type and 92.1 % in
knockout mice (p = 0.57 n.s.), the proportion of polyin-
nervated endplates (2.7% in wild-type and 2.2% in
knockout mice) was not significantly different between
the two groups (p = 0.51; Fig. 8d).
Sensory reinnervation of hindpaw glabrous skin
The extent of sensory reinnervation of the glabrous skin of
the hindpaw was assessed at 17 days after sciatic nerve
crush by light microscopy after immunostaining for PGP
9.5. No differences were observed between wild-type and
knockout animals on the control or injured side (Figs. 9a–
f). In the sampled microscope fields (see Methods) the
mean number of immunostained (presumptive regener-
ated) sensory axons in the dermis was 33 for the wild-type
group and 35 for the knockout animals (p = 0.78 n.s.; Fig.
9g). There was an apparent difference between the wild-
type and knockout animals with respect to PGP 9.5-posi-
tive nerve fibres in the uninjured hindpaw where a mean
of 120 axons was counted in the wild-type versus 72 in the
knockout, but this finding was based on only 3 animals
per group, and significance could not be reliably estab-
lished (p = 0.1, Mann-Whitney test).
Anatomical and functional correlates of regeneration after facial nerve injuryFigure 6
Anatomical and functional correlates of regeneration after facial nerve injury. Analyses of facial nerve regeneration 
in wild-type versus knockout mice after crush or transection of the facial nerve. Fig. 6a illustrates DiAsp-labelled neurons in the 
ipsilateral facial nucleus of a knockout mouse 14 days after facial nerve crush; scale bar = 100 µm. Fig. 6b shows Fluorogold 
(FG)-labelled neurons in the facial nucleus of a wild-type mouse in a coronal section of the ipsilateral pons 28 days after facial 
nerve transection; scale bar = 100 µm and applies to Fig. 6c also. Fig. 6c shows FG-labelled neurons in the contralateral (unin-
jured) facial nucleus of the same mouse as Fig. 6b. Note that some injured neurons are larger and that they are distributed 
throughout the facial nucleus rather than being clustered at its lateral edge, as in the uninjured facial nucleus. Fig. 6d shows his-
tograms of the time taken for the blink reflex and spontaneous whisker twitching to reappear after facial nerve crush in 4 wild-
type (black columns) versus 4 knockout (grey columns) mice. The means and standard errors of the means are shown at the 
top of each column. No differences were apparent between the wild-type and knockout groups for either test. Retrogradely 
labelled neurons were counted in the facial nucleus of 3 wild-type versus 2 knockout mice 14 days after facial nerve crush 
(DiAsp labelling; Fig. 6e – no statistical analysis performed), in 8 wild-type versus 8 knockout mice 30 days after facial nerve 
transection (FG labelling; Fig. 6f) and in 4 wild-type versus 4 knockout mice 40days after facial nerve transection (DiAsp label-
ling; Fig. 6g). Differences between wild-type and knockout mice do not reach significance, at any survival time and with either 
retrograde label.Page 8 of 22
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Ultrathin sections of the digital nerves in the fourth toe
distal to a sciatic nerve crush were analysed by electron
microscopy 17 and 21 days after a sciatic nerve crush to
compare numbers of regenerating unmyelinated and
myelinated axons (e.g. Fig. 10a). There were no gross mor-
phological differences in the ultrastructure of the digital
nerves of wild-type and knockout mice 17 days after a sci-
atic nerve crush. All axons were unmyelinated and the
mean number counted in the dorsal digital nerves of wild-
type mice was 78.3 (median 75.5; SD 38) compared to a
mean of 90.3 axons in the knockout mice (median 93; SD
45) (p = 0.63; Fig. 10e). In the mice surviving 21 days after
sciatic nerve crush, premyelinating axons (Fig. 10b) and
remyelinating axons (Fig. 10c) were counted in all digital
nerves (Fig. 10a) of the ipsilateral fourth toe. Wild-type
Retrograde labelling of DRG after sciatic nerve injuryFigure 7
Retrograde labelling of DRG after sciatic nerve injury. Anatomical analyses of regeneration of sensory axons after sci-
atic nerve injuries in wild-type versus knockout mice. Figs. 7a-c show composite images made up by merging the entire z-series 
of optical sections through L5 DRG in wild-type (Fig. 7a) and knockout mice (Fig. 7b) 13 days after sciatic nerve crush and 2 
days after injection of DiAsp into the skin of the hindpaw. Fig. 7c shows the control DRG (no sciatic nerve injury) from the 
same animal as Fig. 7b. Figs. 7d and e show a similar comparison of labelling in wild-type and knockout mice 90 days after sciatic 
nerve crush. Scale bar = 200 µm and applies to Figs. 7a-e. Figs. 7f and g compare the numbers of labelled cells in L5 DRG 13 
days (Fig. 7f) and 90 days (Fig. 7g) after sciatic nerve crush in wild-type (N = 8 + 8; black columns) versus knockout mice (N = 
8 + 8; grey columns). The quantitative analyses show that there are no statistically significant differences in the numbers of ret-
rogradely labelled DRG cells (and thus in the extent of sensory axon regeneration) between wild-type and knockout mice at 
either short or long postoperative survival times.Page 9 of 22
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the 4th toe digital nerve (median 11.5; SD 7.71) compared
to a mean of 12.8 axons (median 12.5; SD 6.37) in the
knockout mice (p = 0.91; Fig. 10f). In summary, the regen-
erative growth of sensory axons into digital nerves after
sciatic nerve crush appears to be unaffected by the NG2
null mutation.
Axon counts in the tibial nerve after sciatic nerve crush
Transverse sections of the tibial nerve 5 mm distal to a sci-
atic nerve crush injury site were analysed 15 days after
injury. The mean number of myelinated axons in wild-
type mice was 2375, compared to 3087 in knockout mice.
Estimates of the surface area of the wild-type and knock-
out tibial nerve cross sections were sufficiently similar to
suggest that overall size differences in the nerve cross sec-
Silver-cholinesterase stained motor end plates after sciatic nerve injuryFigure 8
Silver-cholinesterase stained motor end plates after sciatic nerve injury. Longitudinal sections of soleus muscle 7 
days (Fig. 8a) and 10 days (Figs. 8b and c) after sciatic nerve crush showing that regenerating axons have not reached/reinner-
vated end-plates at 7 days but extensive reinnervation has occurred by 10 days in both wild-type (Fig. 8c) and knockout (Fig. 
8b) mice. Some endplates were apparently not reinnervated at 10 days (e.g. at arrowhead in Fig. 8c) and a few appeared to be 
innervated by more than one axon (e.g. at arrow in Fig. 8c). Bar = 100 µm in a and applies to c also; bar = 50 µm in b. Fig. 8d 
shows quantitative data on the extent of reinnervation of end-plates 10 days after sciatic nerve crush, expressed as the per-
centages of end-plates without axons, with a single reinnervating axon and with more than one reinnervating axon for wild-
type (N = 6; black columns) and knockout mice (N = 6; grey columns). No significant differences in the timing, extent or type 
of reinnervation were detected.Page 10 of 22
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PGP 9.5 immunohistochemistry for axons in plantar hindpaw skin after sciatic nerve injuryFigure 9
PGP 9.5 immunohistochemistry for axons in plantar hindpaw skin after sciatic nerve injury. Sections of glabrous 
hindpaw skin in wild-type (Figs. 9a, c and e) and knockout mice (Figs. 9 b and d) illustrating the extent of sensory reinnervation 
(PGP 9.5 immunopositive axons) after sciatic nerve crush. Figs. 9a and b show sections from uninjured wild-type and knockout 
mice, and Figs. 9c and d show similar areas of wild-type and knockout mouse skin 17 days after sciatic nerve crush. In the con-
trol material the sensory axons are concentrated in the superficial dermis (D) but are not present in the epidermis (E) or in 
subdermal musculature (M) and their distribution and extent is comparable in both wild-type and knockout mice. Seventeen 
days after nerve crush a few sensory axons have regenerated into the dermis to about the same extent in both wild-type and 
knockout animals. Figs. 9e and f are enlargements of the boxed areas in Figs. 9b and d, and illustrate the relative paucity of 
regenerating PGP 9.5+ axons in the dermis 17 days after sciatic nerve section (e.g. at arrow in Fig. 9f) compared with the dense 
innervation in control skin (e.g. at arrowheads in Fig. 9e). Bar in Fig. 9a = 100 µm and also applies to b – d; bar in Fig. 9e = 20 
µm and applies to f also. Fig. 9g compares counts of PGP 9.5-positive axons in glabrous hindpaw skin 17 days after sciatic nerve 
crush, in wild-type (N = 6) versus knockout mice (N = 6). There is no significant difference.
BMC Neuroscience 2007, 8:80 http://www.biomedcentral.com/1471-2202/8/80
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Electron microscopy of regenerating axons in the digital and tibial nervesFigu e 10
Electron microscopy of regenerating axons in the digital and tibial nerves. Figs. 10a – d shows transverse sections of 
digital nerves of the fourth toe 21 days after sciatic nerve crush. In Fig. 10a an entire nerve is shown at low magnification (bar 
= 10 µm). Fig. 10b shows a regenerating axon (AX) with 2–3 wrappings of Schwann cell processes ('premyelinated' axon; bar = 
200 nm), and Fig. 10c shows a large regenerating axon with a thin semi-compacted myelin sheath and satellite Schwann cell 
(SC) (remyelinating axon; bar = 200 nm). Both of these axons would have been counted in the analysis for Fig. 10f. Fig. 10d 
shows unmyelinated regenerating axons, some surrounded by a thin layer of Schwann cell cytoplasm (at arrowhead) and oth-
ers embedded within Schwann cell cytoplasm (e.g. at arrow), neither of which would have been counted. Bar = 500nm. Figs. 
10e shows counts of all axons and Fig. 10f of remyelinating axons only in the digital nerves of the fourth toe of wild-type (N = 
6; black columns) and knockout mice (N = 6; grey columns) 17 days (Fig. 10e) and 21 days (Fig. 10f) after sciatic nerve crush. 
Difference between axon counts in wild-type and knockout mice are insignificant. Fig. 10g shows counts of myelinated and 
remyelinating axons in the tibial nerve 15 days after, and about 5 mm distal to, a crush lesion of the sciatic nerve in 8 wild-type 
(black column) and 6 knockout mice (grey column). Although the mean fibre count was 3087 in the knockout and 2375 in the 
wild-type mice, this difference was not statistically significant.
BMC Neuroscience 2007, 8:80 http://www.biomedcentral.com/1471-2202/8/80tions were unlikely to be a confounding factor in the
numerical estimates. The difference in the number of
regenerating myelinated axons between wild-type and
knockout animals was not statistically significant (p =
0.164; Fig. 10g).
Facial motor nucleus neuron counts after facial nerve injury
The numbers of facial nucleus neurons retrogradely
labelled with Fluorogold (FG) applied to the whisker pad
27 days after facial nerve transection and 3 days before the
animals were killed, were determined in 8 wild-type and
8 knockout mice (Fig. 6b). The mean number of labelled
neurons in the wild-type mice was 101.7 and in knockout
mice was 107.6 (p = 0.77 n.s.; Student's t-test; Fig. 6f).
In order to confirm that retrograde label was being
uptaken sufficiently, a further 4 wild-type and 4 knockout
mice received DiAsp 37 days after facial nerve transection
(3 days before sacrifice). Wild-type mice had a mean of
194.3 labelled neurons and the knockout mice a mean of
300.3 labelled neurons (p = 0.25 n.s.; Mann-Whitney test;
Fig. 6g).
Similarly, the numbers of facial nucleus neurons retro-
gradely labelled with DiAsp applied to the whisker pad 12
days after facial nerve crush (at the same level as transec-
tion injury) and 2 days before the animals were killed,
were determined in three of the wild-type and three of the
knockout mice used for assessing functional recovery (one
of which was excluded because of poor retrograde label-
ling; Fig. 6a). The mean number of labelled neurons in
wild-type mice was 320 and in knockout mice was 170.5.
This difference could not be tested for statistical signifi-
cance because of the small number of animals included in
these groups (Fig. 6e).
The fact that there were apparently more DiAsp-labelled
neurons in the knockout mice than in the wild-type mice
after facial nerve transection, but more in the wild-type
than in the knockout mice in the facial nerve crush group
further suggests that the difference between wild-type and
knockout animals in the crush group was not significant
and reinforces the conclusion that the absence of NG2 in
the knockout mice has no detectable effect on the regen-
eration of axotomised facial nerve axons.
These findings are entirely consistent with those obtained
with FG, thus strengthening confidence in DiAsp-based
results. The control side facial nucleus had a mean of
305.4 neurons labelled with FG in the wild-type mice and
279 neurons labelled in the knockout mice (p = 0.3 n.s.;
Student's t-test; Fig. 6c), suggesting that there was very lit-




The role of NG2 in the injured nervous system is contro-
versial. Although NG2, a molecule widely regarded as a
potent inhibitor of axonal regeneration, is strongly
expressed at injury sites in the CNS, where regeneration is
abortive, it is also strongly expressed in injured peripheral
nerves, where axonal regeneration is vigorous (e.g.
[10,11,15,27]; and see review by [4]). It might have been
expected, therefore, that the absence of NG2 would
enhance axonal regeneration in the CNS and/or reduce
regeneration in peripheral nerves. Our findings were con-
sistent and in some respects surprising: the absence of
NG2 had no effect on axonal regeneration in vivo. Specif-
ically, we could find no evidence that regenerative growth
of dorsal root axons into the spinal cord after dorsal root
injury, or of ascending (sensory) axons within the spinal
cord following dorsal column injury, was enhanced in the
NG2 knockout mice. Similarly, descending corticospinal
tract axons failed to show enhanced regeneration in NG2
knockout mice following spinal cord injury. In addition,
we have shown, by quantitative methods and for the first
time, that sciatic nerve fibres, both motor and sensory,
and facial (motor) nerve fibres, regenerated and re-estab-
lished functional innervation of target tissues to the same
extent and at the same speed in the NG2 knockout and
wild-type groups.
Because there is evidence that neurons may vary in their
sensitivity to NG2 (see below) it is important that we have
examined regeneration in a number of models. Two dif-
ferent populations of projection axons within the spinal
cord (dorsal column sensory axons and CST axons), dor-
sal root axons at the PNS/CNS interface, and motor and
sensory axons of two peripheral nerves (sciatic and facial)
were all tested for possible effects of the absence of NG2
on regeneration after axotomy. Furthermore, in the case of
the injured peripheral nerve, different types of lesion were
examined, and both functional and multiple types of ana-
tomical analyses of regeneration were carried out. In all of
the systems and experimental conditions tested we found
only insignificant differences between NG2-deficient and
normal animals. We therefore conclude that: i) NG2, on
its own, does not exert a profound influence on the regen-
erative growth of peripheral nerve fibres; and ii) absence
of NG2 from the microenvironment of the CNS does not
enhance the regenerative growth of injured axons or facil-
itate the entry of regenerating dorsal root axons into the
CNS even when the regenerative potential of the DRG
cells is enhanced by a conditioning lesion. In other words,
NG2 cannot be viewed as a major cause of failure of
axonal regeneration within or into the CNS. The latter
conclusion is entirely in keeping with the recent findings
of de Castro et al. [28], who carried out closely related
studies on NG2 knockout mice. They transected the spinalPage 13 of 22
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tion of immunohistochemically visualised CGRP-con-
taining (presumptive sensory axons) into the NG2-rich
scar tissue at the transection site was no more extensive in
the knockout mice than in the wild-type controls, and that
penetration into the scar tissue of serotoninergic (5HT-
immunopositive) axons was greater in the wild-type than
in the knockout mice.
Our findings and conclusions are also in line with other
evidence that NG2 is neither a major inhibitor of axonal
regeneration in the CNS nor a promoter of longitudinal
regeneration in peripheral nerves. This includes the recent
work of Yang et al. [22] which provides some of the
strongest and most direct in vitro evidence that NG2-
expressing cells do not inhibit or repel growing/regenerat-
ing neurites, and indeed provides both in vitro and in vivo
data suggesting the opposite, albeit based heavily on CNS
neurons derived from neonatal rather than mature ani-
mals (see below).
NG2 as an inhibitor of axonal regeneration in the CNS
A number of previous in vivo studies have suggested that
NG2 and other CSPGs play an important part in limiting
axonal regeneration in the CNS. NG2 is the most strongly
upregulated CSPG at CNS injury sites, with a time course
very closely matched to the arrested growth of axonal
sprouts [13,27], and enzymatic degradation of CSPGs (in
particular, removal of chondroitin sulphate gly-
cosaminoglycans by chondroitinase ABC) promotes
regenerative axonal growth in the adult CNS [29-31].
However, such enzymatic degradation is not specific to
NG2 and will affect many other molecules with potential
axon growth inhibiting properties and it is relevant that
there are strongly inhibitory domains in the NG2 core
protein which would be unaffected by treatment with
chondroitinase ABC [7]. More recently, Tan et al., [18]
have described more direct evidence that NG2 is involved
in inhibiting CNS regeneration by well controlled studies
of regenerative growth of transganglionically CTB-
labelled dorsal column axons at thoracic cord transection
lesion sites in young adult rats. They demonstrated a con-
vincing enhancement of growth into (and beyond) the
lesion site, when NG2 was neutralised with function-
blocking monoclonal antibodies applied directly at the
lesion site, especially when the DRG neurons were primed
with a conditioning lesion of the sciatic nerve. We recog-
nise that the work of Tan et al. provides a strong challenge
to the conclusion de Castro et al. and we have reached on
the basis of our studies of NG2 knockout mice. A possible
explanation of the effects of the antibody reported in the
study of Tan et al. is that they may have resulted from
modulation of the behaviour of NG2-expressing cells or
cell complexes, rather than by direct blocking of axon/
NG2 interactions.
NG2 as a facilitator of regeneration in peripheral nerves
Whether or not NG2 has an insignificant role in prevent-
ing axonal regeneration in the CNS – as our findings sug-
gest – or is a contributory factor in this process, NG2 is
upregulated in vigorously regenerating peripheral. Hence
it may be that NG2 has facilitatory roles with respect to
axonal regeneration, especially in the PNS where it has
been suggested that NG2 may promote enhanced mobil-
ity of non-neuronal cells after injury, thereby aiding the
formation of cellular (Schwann cell) bridges to act as a
supportive substrate for regenerating axons [15,32,33].
We have also previously suggested, based on its distribu-
tion within normal and injured peripheral nerve, that a
plausible role for NG2 might be to facilitate regeneration
by helping to confine regenerating axons within the
endoneurial compartment and/or within the bands of
Von Büngner of the distal stump [15]. However, our find-
ing that regeneration of sensory and motor axons in
peripheral nerves is not reduced or delayed in NG2 knock-
out mice suggests that any such effects are of very minor
significance for peripheral nerve regeneration.
Potential confounding factors
It is pertinent to consider why the absence from the trans-
genic mice of NG2, a molecule with powerful effects in
vitro, had so little effect on axonal regeneration in vivo.
First, it is possible that NG2 has a redundant role in this
process since NG2 is only one of a number of potential
growth inhibitory or repulsive molecules at injury sites in
the nervous system. For example, NG2, tenascin-C and
CSPGs other than NG2 are expressed in similar regions of
lesion sites in spinal cord (e.g. the meningeal scar) and
peripheral nerves (the perineurium and the surface of
bands of Von Büngner) [27,34-37]. It would be interest-
ing to analyse with immunohistochemistry whether these
molecules are upregulated in the NG2 KO mice compared
to wild-type mice in the tissues studied.
Second, elimination of the NG2 gene may have induced
upregulation of other molecules with similar functions
during development, thus further compensating for any
effects of the absence of NG2 in the knockout animals.
Conditional knockout and/or knockdown experiments
(e.g. with siRNA) would be necessary to test this hypothe-
sis.
Third, it is also possible that the neuronal populations
investigated in this study were particularly insensitive to
NG2. It is known that neuronal populations differ in their
responsiveness to NG2 in vitro [6,19,20] and in vivo [28],
and it is conceivable that (some of) the neuronal popula-
tions we examined do not normally express receptors for
NG2 and are thus intrinsically less responsive to NG2
than other populations. However, among neuronal types
that have been reported to show inhibition of neuritePage 14 of 22
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neocortical neurons (albeit not specifically CST neurons
[9]). This and the fact that we tested several types of neu-
rons make it extremely unlikely that our findings are not
generally applicable. It is also possible that age is a rele-
vant factor when considering the negative findings in our
study. Thus we used adult animals and studied regenera-
tion in vivo whereas much of the data suggesting inhibi-
tory effects of NG2 on axonal growth derive from in vitro
studies using embryonic or neonatal neurons: for exam-
ple, embryonic or neonatal rat (or chick) DRG neurons
[6,9,38]; rat E17 cortical neurons [9]; E24-25 chick retinal
ganglion cells [39]; and early postnatal rat cerebellar gran-
ule cells [6,8]. Inhibition by NG2 of regenerative axonal
growth from adult neurons has not been directly demon-
strated, and it would not be surprising if developing neu-
rons differed significantly from their adult counterparts
with respect to their responsiveness to NG2. However, in
view of the body of (largely indirect) evidence favouring a
role for NG2 in inhibiting axonal regeneration in the
adult CNS (see Introduction and further discussion
below), our failure to find evidence for such a role of NG2
is unlikely to be explicable solely in terms of the age/
maturity of our experimental animals.
Experiments on mice lacking the putative myelin-derived
inhibitory molecule Nogo-A have also failed to show con-
sistent enhancement of axonal regeneration after injury
[40-43], even though treatment with Nogo-A-blocking
antibodies increase sprouting and regeneration of injured
corticospinal neurons [44,45]. Similarly, genetically inac-
tivating the Nogo receptor (NgR) failed to produce signif-
icant regeneration of one class of axon (the corticospinal
tracts) that express the receptor strongly [46,47], whereas
subcutaneous administration of the NgR antagonist
NEP1-40 enhanced regeneration of corticospinal axons
[48]. The reason for the discrepancy between genetic and
pharmacological inactivation of both Nogo and NgR is
not clear [49]. Part of the lack of effect of knocking out
NG2 may have been due to the genetic background of the
mice we studied- C57BL/6. Genetic background can have
considerable effects on axonal regeneration in strains of
transgenic mice. Recently Dimou et al. [50] showed that
corticospinal axons regenerated less well in Nogo-A
knockout mice with a C57BL/6 background (as used in
the present study) than in knockout mice with a 129X1/
SvJ background, a finding that may be produced by a
weaker intrinsic regenerative response by neurons from
the C57BL/6 strain. None the less, C57BL/6 mice can
regenerate axons vigorously following peripheral nerve
injury and intrinsic CNS neurons from such animals can
regenerate axons into peripheral nerve implants in the
brain (unpublished observations). If NG2 was the major
factor preventing axonal regeneration in the spinal cord of
C57BL/6 mice, some enhancement of regeneration in the
knockout animals would have been expected.
Conclusion
Our studies suggest that NG2 is not a major inhibitory
molecule preventing regeneration in the CNS and, further,
that it is not essential for successful axonal pathfinding,
regeneration and functional reinnervation in injured
peripheral nerves. It is conceivable that if CNS regenera-
tion-promoting interventions such as enhancing the
intrinsic regenerative ability of CNS neurons, expressing
neurotrophic molecules to support regenerating axons
and neutralising other putative inhibitory molecules were
to be applied, NG2 knockout mice would show enhanced
regeneration relative to wild-type mice. However, such
studies have not yet been carried out and for the moment
the evidence that NG2 is not a key inhibitor of axon regen-
eration appears to be very strong.
Methods
Phenotyping
NG2 knockout mice were bred with C57BL/6 wild-type
mice (Harlan, UK) to produce a breeding stock of hetero-
zygous mice, the offspring of which were phenotyped as
follows. Tailsnips from all mice were sectioned at 12 µm
in a cryostat and mounted on gelatinised glass slides
along with sections of tailsnips from known wild-type
mice as a positive control. The sections were post-fixed for
5 minutes with 4% paraformaldehyde in 0.1 M PBS (PFA),
rinsed (x3) in 0.1 M TBS containing 0.05% Tween deter-
gent (TNT), and incubated with 0.3% H2O2 for 15 min-
utes, rinsed again in TNT and placed for 1 hour in 10%
normal goat serum, 1% BSA and 0.1% Triton X-100
(Sigma, Dorset, UK) made up in TBS. The polyclonal anti-
NG2 antibody was then added (1:5000) and the sections
incubated for 72 hours at 4°C. (A polyclonal antibody
was used in preference to a monoclonal antibody because
it would be expected to recognise many sites on the NG2
protein, and therefore be more likely to detect a (possibly
functional) truncated form of NG2 in the KO mouse). The
sections were then washed again in TNT (x3) and incu-
bated in Alexafluor-488- conjugated goat anti-rabbit
biotinylated IgG secondary antibody (Molecular Probes;
1:400) for two hours, washed in TBS and coverslipped
with DABCO anti-fade medium. Mice with no evidence of
NG2 staining, following comparisons with positive con-
trol tissue (see Fig. 1), were designated as knockouts (KO)
and used in experiments with age and sex matched
C57BL/6 mice as wild-type (WT) controls. Homozygous
mutants were viable, fertile, and morphologically indis-
tinguishable from wild-type mice.
General surgical procedures
All animal procedures were performed in accordance with
local ethical committee and UK Home Office approvals.Page 15 of 22
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were used, with wild-type and transgenic mice matched
for age and sex. For all experiments the animals were
coded and randomised so that their phenotype was
unknown at the time of surgery and in the course of data
analysis. All surgical procedures were performed under
aseptic technique and general anaesthesia. Animals were
initially anaesthetised with 4% halothane and anaesthesia
was maintained with 1.5% halothane (plus oxygen and
nitrous oxide 1:1). In the case of the experiment in which
DiAsp (Molecular Probes, Oregon, USA) was introduced
into whisker pads, anaesthesia was induced by a single
intraperitoneal injection of 150 µl of 2.5% Avertin (tribro-
moethanol; Sigma, Deisenhofen, Germany) per 10 g of
body mass. In animals with sciatic nerve or dorsal root
injuries, approximately 0.5 ml sucrose octa-acetate and
denatonium benzoate (Mentholatum, Glasgow, UK) was
applied to the hindpaw on the injured side to prevent
autophagy. Following surgery, all animals received intra-
muscular buprenorphine (20 mg/kg) opiate analgesic
(Vetergesic; Alstoe Ltd., Yorks., UK) and recovered in an
incubator. See Table 1 for a summary of utilisation of ani-
mals.
CNS injury models
Dorsal column and sciatic nerve conditioning lesions
A midline incision was made over the lower thoracic ver-
tebrae, muscles overlying the spine were stripped and a
bilateral laminectomy performed at T8 to expose the spi-
nal cord. The dura was opened and two puncture holes
were made with a fine insulin syringe, one immediately
medial to the left dorsal roots and the second on the
immediate opposite side of the midline. The points of a
pair of straight-bladed microscissors were inserted verti-
cally into the needle holes and the scissors closed to
transect the left dorsal column. The insulin needle,
marked at 2 mm, was passed across the injury site to
ensure a uniform depth of lesion. Superficial muscles
were sutured and the wound closed. To maximise the
regenerative response of injured ascending axons in the
dorsal column, a conditioning peripheral nerve injury was
performed at the same time as the dorsal column lesion.
The ipsilateral sciatic nerve was exposed at mid-thigh
level, crushed for ten seconds with watchmakers' forceps
(No. 7) and the skin incision was closed with Histoacryl
glue (B. Braun, Melsungen AG, Germany). After 25 days,
the animals were reanaesthetised, the left sciatic nerve
exposed and an incision made into the nerve proximal to
the previous crush site. A fine glass micropipette attached
Table 1: Utilisation of Animals
Number of mice
Experimental procedure(s) KO WT Survival period Analysis performed
Transection of DC at T8; conditioning lesion 
of ipsilateral sciatic nerve; subsequent injection 
of CT-HRP into sciatic nerve for TGL
8 6 21d Regen growth by analysis of labelled sensory axons at/
beyond DC lesion site
Transection of dorsal spinal cord at C6; 
simultaneous injection of BDA into 
contralateral sensorimotor cortex
6 6 21d Regen growth by analysis of labelled CST axons at DC 
lesion site
Transection of L5 dorsal root; conditioning 
lesion of ipsilateral sciatic nerve; subsequent 
injection of CT-HRP into sciatic nerve for TGL
6 6 21d Regen growth by analysis of labelled sensory axons in 
dorsal root and DREZ
Sciatic nerve crush











Recovery of foot withdrawal (sensory) and toe 
spreading (motor) reflexes
Sciatic nerve crush; subsequent injection of 
DiAsp into hindpaw skin
10 10 5d (n = 2)
9d (n = 2)
13d (n = 8)
90d (n = 8)
Extent of sensory axon regen by analysis of 
retrogradely labelled DRG cells
Sciatic nerve crush 9 12 7d (n = 6)
10d (n = 15)
Extent of motor regen by analysis of silver-
cholinesterase preparations of soleus muscle






Sensory reinnervation of skin by PGP 9.5 IHC; regen of 
axons into digital nerves by EM
Sciatic nerve crush 6 8 15d Regen of axons into the distal nerve stump by EM
Facial nerve crush: subsequent application of 
DiAsp to whisker pad
4 4 14d Extent of axon regen by analysis of retrogradely 
labelled facial neurons (n = 8) & recovery of whisker 
twitch and blink reflexes (n = 5)
Facial nerve transection: subsequent 
application of FG or DiAsp to whisker pad
12 12 30d (FG, n = 8)
40d (DiAsp, n = 4)
Extent of axon regen by analysis of retrogradely 
labelled facial neurons
KO = knockout; WT = wild-type; d = days post op; TGL = transganglionic labelling; CST = corticospinal tract; DC = dorsal column; DREZ = dorsal 
root entry zone; IHC = immunohistochemistry; EM = electron microscopy; FG = Fluorogold; Regen = regenerative/regeneration.Page 16 of 22
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the incision, and 1 µl of CT-HRP (dissolved at 14 mg/ml;
List Biological Laboratories) was slowly injected into the
endoneurium. The micropipette was withdrawn and the
sciatic nerve was ligated immediately above the incision
in the nerve to prevent leakage of injectate. The skin inci-
sion was then sutured and the animals allowed to recover
and survive for 3 further days.
Dorsal root injury
The lumbar spine was exposed via a midline dorsal inci-
sion and a unilateral left L4 and L5 laminectomy per-
formed to expose the lower lumbar dorsal roots. The L5
root was identified, transected with microscissors and the
cut ends reapposed and held together with fibrinogen
(Sigma, Dorset, UK). The ipsilateral sciatic nerve was
crushed as described above. After 25 days, the animals
were reanaesthetised and 1 µl of CT-HRP was injected into
the sciatic nerve as described above, in order to label
axons in the dorsal root. As the purpose of these experi-
ments was to test for the ability of regenerating axons to
enter the CNS they are included under the general heading
of CNS injury models.
Controls for spared axons
Because incomplete dorsal column (or dorsal root)
lesions might result in CT-HRP labelling of uninjured
axons in the dorsal column, transverse sections were cut
through the medulla at the level of the gracile nucleus in
every animal in these two experimental groups. These sec-
tions were processed alongside the sections of the injury
site. Three animals with evidence of axon sparing
(labelled axons in or immediately caudal to the gracile
nucleus) were excluded from the study on the basis of
these controls.
Corticospinal tract injury and labelling
The skin over the back of the neck was incised, muscles of
the neck reflected, and the spinal cord exposed by bilateral
laminectomy of vertebrae C6 and C7. The area of dorsal
column between the DREZ and the midline on the left
side was cut using a pair of microscissors, and the lesion
was extended across the midline and checked to extend to
a depth of 2 mm below the dorsal surface of the cord with
a marked needle. Care was taken to undercut and avoid
damage to the dorsal spinal vein. The dura was closed and
overlying muscle and skin sutured. While the animals
remained under anaesthesia, BDA (Molecular Probes,
Oregon, USA; 10% solution in dissolved in 0.1 M PBS)
was injected into the contralateral sensorimotor cortex to
anterogradely label corticospinal tract axons. A 2 × 1 mm
burr hole was made over the right parietal cortex, the dura
opened, and a glass micropipette attached to a Hamilton
syringe was pushed into the cortex from the rostral edge of
the burr hole, at a very shallow angle and advanced for 2
mm in a caudal direction. The pipette tip was kept almost
parallel to the cortical surface and at a depth of no more
than 1 mm. BDA solution (1.7 µl) was then injected while
the pipette was slowly retracted to its entry point. The
pipette was then advanced through the same entry point,
for the same distance and at the same depth but directed
slightly medially with respect to the first injection and a
second aliquot of BDA (1.7 µl) injected in the same man-
ner as the first. Finally the process was repeated a third
time, with the pipette tip directed slightly laterally with
respect to the first injection. Thus a total of approximately
5 µl BDA solution was injected, filling a large area of the
right sensorimotor cortex. The burr hole was then covered
with Gelfoam (Johnson & Johnson, Skipton, UK) and the
scalp incision sutured.
Animals with dorsal column or dorsal root injuries sur-
vived for 28 days and those with CST injuries survived for
21 days. Following an anaesthetic overdose of intraperito-
neal sodium pentobarbitone (Sagatal; Rhône Merieux,
UK) supplemented with halothane, they were perfused
transcardially with 50 ml of PBS followed by 100 ml PFA.
The relevant portions of cervical, thoracic or lumbar spi-
nal cord and dorsal roots were removed and post-fixed for
2 hours in PFA. The tissue blocks, in some cases further
dissected, were then transferred to PBS containing 30%
sucrose for 48 hours. The cryoprotected tissue blocks were
frozen in Tissue-Tek (Sakura, Zoeterwoude, Netherlands)
cooled with dry ice. Serial horizontal sections of spinal
cord were cut on a freezing microtome at 40 µm and col-
lected in 0.1 M PBS.
BDA immunohistochemistry
Free floating sections, maintained in serial order, were
washed twice in 0.05 M TBS containing 0.5% Triton X-100
(TBST), and incubated in 0.3% H2O2 for 15 minutes,
rinsed again in TBST (2 × 10 minutes) and incubated over-
night in 1:200 ABC kit solution (Vector Laboratories, Bur-
lington CA, USA) at 4°C. After two washes in TBST and
one in 0.05 M TBS, sections were incubated in TSA Cy3
(1:400 in 0.05 M TBS) for 30 minutes, washed, mounted
onto gelatinised slides and coverslipped with glycerol
containing DABCO.
Sections were scanned with a Leica TCS NT confocal
microscope. Projection images represented stacks of 10–
20 optical sections merged together (2 scans at each opti-
cal section level), with a resolution of 1024 × 1024 pixels.
Images from wild-type and knockout mice were acquired
under identical exposure conditions.
CT-HRP histochemistry
Free-floating serial sections were processed to reveal CT-
HRP reaction product using tetramethylbenzidine (TMB)
as the chromogen, according to the method of MesulamPage 17 of 22
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then preincubated, on ice, for 30 minutes in a solution of
0.1% sodium nitroferricyanide, 5% 0.2 M sodium acetate
buffer (pH 3.3), 0.005% TMB (dissolved first in a volume
of ethanol that amounted to 2.5% of the total solution)
made up in dH2O. A solution of 0.3% H2O2 was then
added (2% of the total incubation mixture volume) and
the sections incubated on ice until reaction product was
visible (approximately 15 minutes) at which point the
reaction was arrested by 6 × 5 minute washes in 0.02 M
sodium acetate buffer. Sections were collected on gelati-
nised slides, air dried overnight, rapidly dehydrated in
ascending strength alcohol solutions and coverslipped
with DPX (Merck, Poole, UK).
Digital images were taken using a Zeiss Axiophot fluores-
cence microscope equipped with Openlab image process-
ing software.
PNS injury models; functional studies
Sciatic nerve injury
The left sciatic nerve was exposed via a 4 mm longitudinal
incision over the left mid-thigh above the level of origin
of the sural nerve, and crushed for ten seconds with
watchmakers' forceps (No. 7). In other mice, sciatic nerve
crush was supplemented by excision of 3 mm of the
saphenous nerve at mid-thigh level, in order to control for
the possibility that sensory recovery following sciatic
nerve injury might result from sprouting of saphenous
nerve axons [52-54]. In other mice, the left sciatic nerve
was transected with microscissors at the same level as the
crush lesions and the cut ends immediately reanasta-
mosed with 2 × 10/0 sutures. The skin incisions were
closed with Histoacryl glue.
Assessment of functional recovery after sciatic (and saphenous) 
nerve injury
Recovery of sensory function was assessed using Von Frey
hairs. Animals were placed under a glass case on a taut
nylon mesh and allowed to settle for 20–30 minutes, to
allow the test to be performed without restraint and under
conditions of minimal stress [55]. The threshold thickness
of Von Frey hair required to elicit a repeated withdrawal
response was assessed in all animals, prior to nerve injury,
by stimulating the lateral glabrous skin of the hindpaw.
After injury, the time taken for mice to recover the ability
to withdraw their paw in response to the same Von Frey
hair as pre-operatively was assessed twice daily and con-
tinued for two days after recovery of function. At each test-
ing session, the contralateral, uninjured hindpaw was
assessed for comparison. Motor function was tested
immediately after the sensory assessment, by assessing
(recovery of) the toe spreading reflex (involuntary spread-
ing of the digits when the hindlimbs are raised off their
supporting surface by lifting the mouse by the tail).
Facial nerve injury and assessment of functional recovery
The right facial nerve was exposed postero-inferior to the
right ear and crushed immediately distal to the stylomas-
toid foramen for ten seconds with watchmakers' forceps.
The skin incision was closed with Histoacryl glue. Func-
tional recovery was monitored twice daily by visually
checking for recovery of spontaneous whisker twitching
and for the return of the blink reflex (elicited by irritating
the cornea with a thin piece of cotton wool). The left side
was examined at the same time as a positive control.
PNS injury models; anatomical studies
Retrograde labelling of DRG cells
After survival times of 3–88 days (Table 1), 1 µl of DiAsp
was injected into the lateral plantar skin of the hindpaws
both ipsilateral and contralateral to the nerve injury,
under general anaesthesia, using a glass micropipette
attached to a Hamilton microsyringe. Two days later, the
animals were overdosed with anaesthetic and the L4 and
L5 DRG on both sides removed and placed in PFA for 2
hours. The ganglia were then placed whole onto a cavity
slide, coverslipped with glycerol containing DABCO, and
examined and photographed immediately in a confocal
microscope. If labelled cells were present, an average of 25
images was collected through the entire thickness of the
DRG. Retrogradely labelled cells (visible above a fixed
luminescence threshold) were counted using Openlab
image processing software. The exposure time for all
images was kept constant to ensure valid comparisons
between control and injured and between wild-type and
knockout material.
Silver-cholinesterase histochemistry
To examine reinnervation of muscle 7 and 10 days after
sciatic nerve crush, animals were killed by overdose of
anaesthetic and their right and left (control) soleus mus-
cles removed and processed by the method of Namba et
al. [56]. The muscles were fixed, whilst slightly stretched,
in buffered formol-calcium at 4°C for 6 hours, then
placed in 10% sucrose at 4°C overnight. The muscles were
cut at 40 µm with a freezing microtome and the sections
collected in chilled dH2O. Sections were then incubated
for 20 minutes on ice in the following medium: acetylth-
iocholine (10 mg); 0.1 M sodium hydrogen maleate (13
ml); 100 mM tri-sodium citrate (1 ml); dH2O (2 ml); 5
mM potassium ferricyanide (2 ml); sucrose (3 g). They
were then rinsed in dH2O and immersed in potassium fer-
ricyanide (0.25 g/100 ml dH2O) for 30 seconds at room
temperature and rinsed again in three washes of dH2O.
They were then placed in absolute alcohol (2 washes over
1 hour) and returned to dH2O before being transferred
with a glass rod to silver solution with the following com-
position: 50 ml dH2O; 0.05 g CaCO3 double filtered and
then mixed with 0.025 g CuSO4.5H2O; 5 g AgNO3, for
20–30 minutes at 37°C. After rinsing for 5–20 seconds inPage 18 of 22
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hydroquinone; 10 g Na2SO4; 100 ml dH2O) until end-
plates could be visualised under a dissection microscope
(usually 30–120 seconds), washed in dH2O, mounted on
glass slides, dried at 37°C, dehydrated, passed through
Histoclear (National Diagnostics, Georgia, USA) and cov-
erslipped with DPX. Between 300 and 350 motor end-
plates per mouse were counted on the injured and control
side and the relative proportions determined of: dener-
vated endplates; endplates innervated by one axon; and
endplates innervated by two or more axons.
PGP 9.5 immunohistochemistry
Reinnervation of skin was examined, after PGP 9.5 immu-
nostaining of sensory axons, in mice surviving 17 days
after sciatic nerve crush (as described above). The animals
were killed by anaesthetic overdose and both hindpaws
removed and placed into PFA for 3 hours, followed by
immersion in 30% sucrose in TBS overnight. An area of
lateral glabrous skin was dissected from each hindpaw
and frozen in Tissue-Tek cooled with dry ice. Frozen sec-
tions were cut at a 12 µm perpendicular to the skin sur-
face, collected on glass slides, air dried for 30 minutes and
washed with TBS before immersion for 30 minutes in a
blocking solution of 10% normal goat serum in TBS con-
taining 0.1% Triton X-100 and 1% BSA. Sections were
then reacted overnight with PGP antibody (1:500 in
blocking solution) in a sealed humidified chamber at
room temperature. After 3 washes in TNT, the sections
were incubated with goat anti-rabbit Alexofluor 488
(1:400 in TBS) for 2 hours, followed by one rinse in TNT
and 2 rinses in TBS. Slides were coverslipped using
DABCO and the lateral edge of glabrous hindpaw exam-
ined and photographed (in a Zeiss Axiophot microscope
using a × 20 objective lens) from a random sample of 6
sections per foot. From these images, the total numbers of
axons labelled with PGP 9.5 that had regenerated into the
dermis were counted in the skin samples from the ipsilat-
eral hindpaw of all mice (Table 1), and from the contral-
ateral hindpaw of 3 wild-type and 3 knockout mice.
Electron Microscopy
The extent of axonal regeneration into distal nerve
branches was analysed by EM in the same group of 12
mice used to examine skin reinnervation by PGP immu-
nohistochemistry (17 day survival) and in an additional
group of mice with identical unilateral sciatic nerve crush
injury and 21 day survival. Following anaesthetic over-
dose, the 4th toe of both hind feet was amputated and
placed in fixative solution (2% paraformaldehyde and
2.5% glutaraldehyde in PBS) for 24 hours followed by
immersion in 5% EDTA for 48 hrs at 4°C to soften bone.
The toes were post-fixed in 1% OsO4 in 0.1 M phosphate
buffer (PB) at 4°C for 1 hour, washed in PB followed by
three washes in dH2O, stained with 2% uranyl acetate (in
dH2O) for 40 minutes at 4°C, washed in dH2O, dehy-
drated, passed through propylene oxide, placed in a 50:50
mixture of propylene oxide and Agar resin (12 g Agar; 8 g
dodecenyl succinic anhydrite (DDSA); 5 g methylnadi-
canhydride; 0.4 ml benzyldimethylamine) for 45 minutes
and then placed in fresh Agar resin overnight at room tem-
perature on a rotator. Specimens were then placed in fresh
resin for a further 24 hours before being placed in blocks
in an oven at 60°C for 36 hours to polymerise the resin.
Transverse semithin sections (ca. 1 µm) of both ipsilateral
and contralateral toes were cut on an ultramicrotome and
stained with toluidine blue to localise dorsal digital
nerves. Ultrathin transverse sections through the nerves
were cut with a diamond knife, collected on Formvar-
coated slot grids, stained with lead citrate for 10–15 min-
utes, and examined in a JEOL 1010 electron microscope
operated at 60 kV. Images were recorded on Kodak EM
film 4489. In animals that had survived 17 days, numbers
of unmyelinated axons in the dorsal digital nerves were
counted. In the animals that survived 21 days, only remy-
elinating axons of all digital nerves of the 4th toe were
counted.
Axonal regeneration in the tibial nerve, just below the
lesion site was also examined by EM in an additional
group of mice, 15 days after sciatic nerve crush. These ani-
mals were given an anaesthetic overdose and perfused
transcardially with 50 ml of PBS followed by 100 ml of
2% paraformaldehyde and 2.5% glutaraldehyde in PBS. A
segment of tibial nerve 5 mm distal to the crush site was
removed, post-fixed for 2 hours, osmicated (1 hour in 1%
OsO4 at 4°C), dehydrated and processed into Araldite
resin (10 g DDSA; 10 g Araldite (CY212); 0.8 g dibutyl-
phthalate) warmed for two minutes at 60°C and then
mixed with 0.4 ml BDMA. Following polymerisation,
transverse thin sections of the tibial nerve 5 mm distal to
the crush site were stained with lead citrate, examined by
EM and myelinated axons counted. Independent blinded
counts were made by two observers to reduce the impact
of bias in relation to identification criteria for axons.
Retrograde labelling of facial motor neurons
The extent of facial nerve regeneration after transection
was assessed with the retrograde label Fluorogold (FG).
The facial nerve was transected with microscissors imme-
diately below the stylomastoid foramen and the cut ends
apposed and held together by fibrinogen. They were
anaesthetised 3 days before sacrifice and a 2 × 2 mm piece
of Gelfoam previously soaked with 4 µl FG (2 granules
dissolved in 100 µl PBS) was placed below the skin of the
right whisker pad. As a control FG was also applied to the
contralateral whisker pad at the same time in most of the
mice. After a further 3 days, the animals were overdosed
with anaesthetic and perfused transcardially with PBS fol-
lowed by PFA, as described above. A block of tissuePage 19 of 22
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cryoprotected for 24 hours in PBS containing 30%
sucrose. Frozen coronal sections through the pons (con-
taining the facial nucleus) were cut at 40 um, collected in
PBS, mounted in serial order on slides, coverslipped with
DABCO, and examined immediately in a Zeiss Axiophot
microscope. Counts were made of labelled neurons in the
injured and control side facial nucleus (above a fixed
luminescence threshold), using Openlab image process-
ing software and the final number corrected for variability
in the optical slicing of nuclei using Abercrombie's count-
ing method [57].
In other mice, DiAsp was used as the retrograde label as a
control. The facial nerve was transected and 4 µl DiAsp (2
granules dissolved in 100 µl DMSO) soaked in a Gelfoam
pad placed in the whisker pad 37 days after injury, after
which the animals were allowed to survive for 3 days. The
facial nucleus of these animals was analysed as described
above.
In addition, 6 of the 8 mice used for functional assessment
of facial nerve recovery after crush injury were also used for
anatomical assessment by retrograde labelling with
DiAsp. They were anaesthetised 12 days after the facial
nerve crush and DiAsp placed in the whisker pad. After a
further 2 days, the animals were given an anaesthetic over-
dose and their facial nuclei examined as described above.
Statistical analysis
Differences between wild-type and knockout mice with
respect to both functional and anatomical analyses of
axonal regeneration were evaluated for significance by
using Student's two-tailed unpaired t-test when there were
6 or more animals per experimental group, or a Mann-
Whitney test if there were fewer animals or if the data from
any group did not represent a normal distribution. In one
experiment, the standard deviation of a group was zero,
which precludes such statistical analysis and a two-tailed
Fisher's exact test was used to calculate a p value. For all
experiments, a p value of < 0.05 was considered to be sig-
nificant.
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